PulseArk Technologies Shines at Bangkok Business Challenge
June 18, 2025 — The PulseArk Technologies team, led by postdoctoral fellow Henry Palfrey, Ph.D., from the University of Arkansas for Medical Sciences (UAMS), made a notable impression at the prestigious Bangkok Business Challenge, held from May 22-24 at the Sasin School of Management. Competing against over 300 applicants globally, PulseArk not only reached the semifinals but also earned the Best Presentation Award, distinguishing itself as a standout among just 20 selected teams.
Palfrey, who specializes in radiation-induced kidney injuries, is part of UAMS’s T32 Health Sciences Innovation and Entrepreneurship Training Program. His startup is developing VoluSense, a device designed to detect internal bleeding earlier than current practices, a breakthrough that could enhance emergency medical responses.
“The competition provided invaluable feedback and momentum as we advance VoluSense toward market entry,” shared Palfrey, who serves as the startup’s chief technology officer. The device, crafted through collaboration with engineers at the University of Arkansas at Fayetteville and UAMS medical professionals, leverages proprietary algorithms to assess blood loss via venous pressure waveforms.
PulseArk, recently awarded a $1.9 million grant from the Department of Defense’s Congressionally Directed Medical Research Programs, aims to finalize its prototype and commence preclinical studies this summer, with aspirations for pilot testing in Arkansas hospitals by 2028.
Prof. John D. Imig, director of the T32 program, commended the team’s drive and vision. “Their success in Bangkok showcases their innovative spirit and highlights the significance of interdisciplinary training,” he stated.
Team members include BreeAnna Scott, M.S., as CEO; Victoria Bourgeois, MBA, as chief strategy officer; Asha Lee, M.S., as CFO; and Tanner Moore, M.S., as chief product officer. The trajectory of PulseArk Technologies reflects a commitment to bridging scientific innovation with practical clinical applications.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
